3rd Quarter - Termination
BROWNSTEIN HYATT FARBER SCHRECK, LLP for CEPHEID
Client
Income
$20,000
Expenses
—
Terminated
Jul 31, 2024
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to diagnostic testing and reimbursement. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act issues related to hepatitis-C including HEP-C testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID PHILLIP COHEN | — |
| EMILY FELDER | — |
| ELIZABETH ANNE MAIER | — |
| THOMAS ROBB MOTTUR | — |
| DAVID REID | — |
| SAGE SCHAFTEL | — |
| ADAM STEINMETZ | — |
| RUSSELL W. SULLIVAN | — |
| DEEMA TARAZI | — |
| ANDREW USYK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.